Orna Therapeutics
Yael Zigelman is a scientist with extensive experience in synthetic biology and plasmid production. Currently serving as the Head of Plasmid Production at Orna Therapeutics, Yael leads large-scale DNA purification and cloning projects while providing expertise in complex cloning tasks. Previous roles include Senior Research Associate I at LifeMine Therapeutics, where Yael designed and executed cloning of gene clusters, and as a Synthetic Biology Scientist at BiomX Inc., focusing on engineered phages and bacterial strains. Educational qualifications include a Master of Science in Molecular Genetics from the Weizmann Institute of Science and a Bachelor's degree in Biotechnology from Tel Aviv University. Additionally, Yael has experience in teaching and customer service, showcasing a diverse skill set.
This person is not in any teams
This person is not in any offices
Orna Therapeutics
1 followers
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way it treats disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.